Coronary Calcium Score: What This Heart Test Can Tell You

What Is a Coronary Calcium Score?

Imagine you could peek inside the walls of your heart’s arteries and see whether plaque is quietly building up, years before it causes a heart attack. That’s essentially what a coronary artery calcium (CAC) score does.

A coronary artery calcium score (also called a CAC score or calcium score) is a number generated from a quick, non-contrast CT scan of your heart. It measures how much calcified plaque (KAL-sih-fyed PLAK), a hardened form of cholesterol-laden buildup, is sitting in your coronary arteries. The scan takes about 10 minutes, requires no needles or contrast dye, and exposes you to a small amount of radiation (roughly 1 millisievert, similar to a mammogram).

The resulting score, called the Agatston score (uh-GAT-ston), was first developed in 1990 and remains the standard method used worldwide. A score of zero means no detectable calcified plaque was found. Higher numbers indicate more plaque. As a 2023 review in the Journal of Cardiology explains, the score is broken into risk categories:

The core idea is straightforward: the more calcium in your coronary arteries, the more atherosclerosis you have, and the higher your risk of a future heart attack or stroke. But the real value of this test lies in the details: who should get it, when it’s most useful, and what to do with the results.

Why Do Doctors Order This Test?

Heart disease is the leading cause of death in most countries. A frustrating reality is that for many people, the first sign of heart disease is a heart attack. Standard risk calculators use factors like age, blood pressure, cholesterol, and smoking status to estimate your 10-year risk. These calculators work reasonably well for large populations but can misjudge the risk for individuals.

This is where the calcium score comes in. It offers a direct look at whether plaque is actually present rather than just predicting whether it might be.

According to a 2023 review of major global guidelines in JACC: Cardiovascular Imaging, guidelines from North America, Europe, Asia, and Australia all recognize the CAC score as a useful tool for refining cardiovascular risk, particularly in people at borderline or intermediate risk (roughly a 5% to 20% estimated 10-year risk of a cardiovascular event). The American College of Cardiology and American Heart Association (ACC/AHA) recommend it as a decision aid when a doctor and patient are uncertain about whether to start statin therapy.

In simpler terms: if your risk calculator puts you in a gray zone, a calcium score can help clarify whether you’re closer to the “lower risk” end or the “higher risk” end.

Related: Intermittent Fasting: What the Latest Science Actually Says

What Does the Research Show About Predicting Heart Events?

The evidence supporting the CAC score as a predictor of cardiovascular events is extensive and consistent across populations.

A 2024 study in Radiology analyzed data from the DISCHARGE trial, which included 1,749 patients with stable chest pain across 26 centers in 16 countries. Over a median follow-up of 3.5 years, participants with a CAC score of 400 or higher had a dramatically higher rate of major adverse cardiovascular events (MACE) compared to those with a score of zero. The prevalence of obstructive coronary artery disease jumped from about 4% in the zero group to 76% in the 400-plus group.

A 2023 study in JACC: Cardiovascular Imaging from the multinational CONFIRM registry found something especially striking: people with a CAC score above 300 who had never had a heart attack had event rates statistically similar to people who had already survived one. In other words, a very high calcium score may put you in the same risk ballpark as someone with established heart disease.

These findings matter because they suggest that people with very high scores might benefit from more aggressive prevention, even if they’ve never had symptoms.

Does a Score of Zero Mean You’re Safe?

A score of zero is generally very reassuring. A 2023 study of nearly 10,900 patients in Heart found that among those with a CAC score of zero, 98.2% were correctly ruled out for obstructive coronary artery disease. The annual risk of a heart attack or cardiac death with a zero score has consistently been estimated at less than 1%.

A 2021 study in The American Journal of Cardiology from the Multi-Ethnic Study of Atherosclerosis (MESA) followed adults aged 45 to 55 with a score of zero for a median of 16 years. Overall cardiovascular event rates remained low: about 4% at 15 years. Non-smokers did especially well.

However, a zero score doesn’t guarantee zero risk. As a 2022 editorial in the Journal of Cardiovascular Computed Tomography points out, roughly 20% of people scored as zero by the standard method may have very early, “subthreshold” calcification that falls below the detection limits. And in younger patients under 45, the Norwegian study in Heart found that the sensitivity of a zero score for ruling out disease dropped to about 82%, likely because younger people are more likely to have soft, non-calcified plaque that doesn’t show up on a calcium scan.

So a zero is a strong reassurance, not a guarantee.

Does Adding a Calcium Score Actually Improve Risk Prediction?

This is where the story gets more nuanced.

A 2022 systematic review and meta-analysis in JAMA Internal Medicine looked at whether adding a CAC score to standard risk calculators meaningfully improved predictions. The pooled improvement in a key statistical measure of discrimination (the C statistic) was 0.036. That’s a real but modest gain. The review also noted that most people who were reclassified to higher risk categories based on their calcium score did not go on to have a cardiovascular event during follow-up (ranging from 5 to 10 years).

This doesn’t mean the test is useless. It means the benefit is mainly in sharpening an already reasonable estimate, not in completely transforming it. And importantly, there is still no randomized controlled trial proving that using a CAC score to guide treatment decisions leads to fewer heart attacks or deaths compared to using standard risk factors alone. The evidence is observational.

A 2021 editorial in JACC: Cardiovascular Imaging emphasized that a large trial comparing CAC-guided therapy to standard care is exactly what the field needs. Until that exists, we’re working with strong but indirect evidence.

How Does a Calcium Score Change What Doctors Actually Do?

A 2022 study from Brigham and Women’s Hospital tracked 839 patients who underwent CAC testing and looked at what happened next in their medical care. The findings were clear:

• Among patients with a non-zero CAC score, prescriptions for lipid-lowering therapy (statins) increased by 114%.
• Aspirin initiation increased by 41%.
• Among those with a CAC score of 100 or higher, 75% were started on new or more intensive lipid-lowering therapy.
• Doctors were more likely to recommend diet and exercise changes for patients with higher scores.
• Rates of additional downstream testing (stress tests, angiograms) were low overall at 9.1%, and testing was mostly limited to patients with CAC scores of 100 or above.

This suggests that the test is doing what guidelines intend: motivating appropriate treatment in higher-risk patients while not triggering a cascade of unnecessary procedures.

A 2023 study in BMC Cardiovascular Disorders involving 5,289 patients with stable chest pain found that incorporating the calcium score into risk assessment models improved the identification of low-risk patients by 19% compared to a strategy based on clinical factors alone. This meant that a significant number of patients could safely avoid further invasive testing.

Can a Calcium Score Help Decide Who Needs a Statin?

This is arguably the most practical use of the test in everyday medicine.

Current ACC/AHA guidelines say that for adults aged 40 to 75 at borderline or intermediate 10-year risk, a CAC score can inform the statin decision:

• CAC = 0: It’s reasonable to defer statin therapy and reassess in 5 to 10 years, as long as you don’t have diabetes, a strong family history of heart disease, or you smoke.
• CAC above 0: The guidelines generally favor statin initiation.
• CAC of 100 or higher (or above the 75th percentile for your age and sex): There’s a stronger case for starting a statin.

The Journal of Cardiology review cited a study showing no significant difference in outcomes between patients with and without statin therapy when their CAC score was zero, but a clear benefit of statins in patients with any detectable calcium. This provides a rational basis for using the score to avoid unnecessary medication in truly low-risk people.

Related: Can Supplements Slow Down Your Liver’s Aging Clock?

Who Benefits Most, and Who Should Be Cautious?

The test is most useful when the treatment decision is genuinely uncertain. According to a 2025 article in JAMA Cardiology, there are three common scenarios where clinicians should think carefully about timing:

When it may be too early

In younger adults (under about 40 to 45), a zero score is less informative because early plaque often hasn’t calcified yet. A 2023 review in Current Opinion in Cardiology found that about one in ten young adults in the general population, and one in three with traditional risk factors, already have detectable CAC. However, the clinical significance of very low scores in young adults is still being studied. A zero score in a 35-year-old with a strong family history does not mean they can ignore risk factors.

When it may be too late

In older adults who are already on statins, or who clearly meet criteria for treatment based on their risk profile, a calcium score adds little to the decision. If you already know you need aggressive treatment, confirming that there’s calcium present doesn’t change the plan.

When it’s repeated too often

Current guidelines suggest a warranty period for a zero score: about 5 to 7 years for low-risk individuals, 3 to 5 years for those at borderline to intermediate risk, and roughly 3 years for higher-risk individuals or those with diabetes. About 25% of middle-aged adults with a zero score will develop detectable calcium within 3 to 7 years, with conversion happening faster in older adults, men, and people with diabetes.

Is the Calcium Score Cost-Effective?

The scan typically costs between $75 and $150 in the United States, but most insurance companies still do not cover it for primary prevention screening. This is a significant barrier.

A 2023 cost-effectiveness analysis in the Portuguese Journal of Cardiology modeled three strategies for patients with low pretest probability of coronary artery disease: (A) no testing, (B) CAC score first, followed by CT angiography only if the score is above zero, and (C) CT angiography for everyone. The CAC-first approach correctly classified 98.9% of cases and was cost-effective compared to no testing, adding about €1,366 per additional correct diagnosis.

A 2021 editorial in JACC: Cardiovascular Imaging described microsimulation modeling suggesting that a CAC-guided strategy was cost-effective for people with a family history of premature heart disease, compared to treating everyone above a standard risk threshold. Still, the authors stressed that a large randomized trial is needed to confirm these models.

Common Questions About Coronary Calcium Scores

Can you lower your calcium score?
Statins and other therapies generally do not reduce the calcium score itself. In fact, statins may slightly increase it because they stabilize plaque (which involves more calcification). What matters is that these treatments reduce the risk of heart events, even if the number on the scan doesn’t drop.

Is the radiation from the scan dangerous?
The radiation dose is about 1 millisievert, comparable to a mammogram or a few months of natural background radiation. For a single scan, the risk is considered very small.

Should everyone get a calcium score?
No. Guidelines recommend it primarily for people at borderline or intermediate cardiovascular risk where the result would change a treatment decision. It is not recommended as a universal screening test for all adults.

Can you have a heart attack with a calcium score of zero?
Yes, though it’s uncommon. Some plaques are soft and non-calcified, and these can still rupture and cause events. A zero score significantly lowers your risk estimate but does not eliminate it.

Where the Science Is Still Uncertain

Several important questions remain unresolved:

• No randomized controlled trial has yet proven that CAC-guided treatment decisions lead to fewer heart attacks or deaths compared to standard risk-factor-based care. The 2022 JAMA Internal Medicine meta-analysis and the 2021 JACC editorial both highlighted this as the central gap in the evidence.
• The optimal approach for younger adults is still being defined. A 2023 review noted that risk factors for calcified plaque in young adults may differ from those in older adults, and the test’s sensitivity for non-calcified disease is limited.
• How often to repeat the test after a zero or low-positive score lacks strong trial evidence, though guideline groups have offered reasonable recommendations based on observational data.
• The scoring system itself may eventually be updated. A 2022 editorial in the Journal of Cardiovascular Computed Tomography discussed how the Agatston method doesn’t account for calcium density patterns or anatomical distribution, and future scoring approaches may be more informative.
• Whether CAC should be combined routinely with other imaging like myocardial perfusion imaging (MPI) for better risk prediction is promising but not yet settled. A 2023 article in Cardiology Clinics suggests that calcium scoring adds diagnostic and prognostic value when performed alongside MPI.

The Bottom Line

Here is what we can say with reasonable confidence based on the current research:

• A coronary calcium score is a well-validated, low-cost, low-radiation test that directly measures calcified plaque in your heart’s arteries.
• A score of zero is strongly reassuring, associated with less than 1% annual risk of major cardiac events and a favorable long-term outlook, especially in non-smokers.
• Higher scores, particularly above 300, are associated with risk levels comparable to established heart disease and typically prompt more aggressive prevention.
• The test is most useful when it changes a decision, specifically for people at borderline or intermediate risk where it can clarify whether statin therapy or lifestyle changes should be intensified.
• It is not recommended as a universal screening test, and timing matters: too young, too old, or too often can limit its value.
• A randomized trial is still needed to prove that using calcium scores to guide treatment leads to better outcomes than standard care alone.

If you’re in the gray zone of cardiovascular risk and wondering whether to start a statin, talk with your doctor about whether a calcium score might help inform that conversation.

Quick Reference: Key Studies

Last updated: February 2026

This article synthesizes findings from peer-reviewed research. It is for educational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any new regimen.